Silica nanocapsules stabilized with a reactive surfactant are synthesized to prevent leaching of toxic surfactant. The nanocapsules show a superior stability and biocompatibility compared with nanocapsules prepared with conventional surfactants.
Silica nanocapsules (SiO 2NCs) are usually prepared with cationic surfactants that are not cytocompatible. Dialysis can be used to remove surfactants but leads to instability of the SiO 2NCs when they are in the presence of proteins or biological media. Herein, SiO 2NCs stabilized with a reactive surfactant are synthesized to prevent leaching upon dialysis. The SiO 2NCs show superior stability and biocompatibility compared with SiO 2NCs prepared with conventional surfactants. The SiO 2NCs can be used in self-healing materials, smart agriculture and biomedical applications.